The search found 3627 results.
Press Release

Imprivata to Present at Two Upcoming Investor Conferences

Lexington, Mass. — October 31, 2014—Imprivata® (NYSE: IMPR) today announced that members of management will participate in two upcoming investor conferences.

Omar Hussain, President and CEO, and Jeff Kalowski, Chief Financial Officer, will present at the Stephens Fall Investment Conference in New York, New York on Tuesday, November 11, 2014 at 1:00 PM ET.

Mr. Hussain and Mr. Kalowski will also present at the Piper Jaffray Healthcare Conference in New York, New York on Wednesday, December 3, 2014 at 9:00 AM ET.

Press Release

Imprivata, Inc. Reports Third Quarter 2014 Financial Results

Imprivata achieves record revenues of $25.3 million, a 41% increase over the comparable period of 2013, and increases annual revenue guidance.

Blog Post

Two-Factor Authentication Considerations for e-Prescribing of Controlled Substances

Make a well-informed decision about which two-factor authentication modalities to introduce to your EPCS process: keep prescriber satisfaction in mind
Blog Post

Four Steps to Successfully Deploy Your Secure Clinical Communications Solution

Learn how to successfully deploy a new, secure communications platform at your healthcare facility: secure your success by planning proactively
Blog Post

The Case for Smarter Clinical Workflows

A seasoned physician shares his perspective on critical cardiology care: improved communication technologies can save time and lives. Learn how now.
News

Imprivata's Sean Kelly: Tighter rules for controlled substances require technology to be successful

Blog Post

How Leading New York Hospitals are Approaching I-STOP Compliance

Learn how leading New York hospitals are critically thinking about, and planning for, I-STOP's mandatory introduction of EPCS processes.
Press Release

Imprivata OneSign 5.0 Expands Capabilities of Healthcare Industry’s Leading Solution for Authentication Management and Virtual Desktop Access

Latest Version of Imprivata OneSign Improves Scalability and Expands Market-Leading Support for Desktop Virtualization Platforms and Thin/Zero Clients 

Lexington, Mass.—December 2, 2014—Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today introduced Imprivata OneSign® 5.0, the newest version of the company’s flagship authentication and access management solution.

Blog Post

Six Steps to a Successful e-Prescribing of Controlled Substances Project: Part 1

Electronic prescribing of controlled substances (EPCS) has many benefits for prescribers, patients, IT, and pharmacy and hospital administration. But the DEA requirements for EPCS introduce complexities that need to be considered when developing a project plan.
Blog Post

How to Successfully Improve your Clinical Communications: Empower your Crew

Learn how to successfully implement a new clinical communications solution: Listen to your clinical crew and empower them to rally together effectively